Lack of cost-effectiveness of omalizumab
- 28 February 2005
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 115 (2) , 429-430
- https://doi.org/10.1016/j.jaci.2004.10.049
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthmaJournal of Allergy and Clinical Immunology, 2004
- The cost-effectiveness of an inner-city asthma intervention for childrenJournal of Allergy and Clinical Immunology, 2002
- National Asthma Education and Prevention Program Working Group Report on the Cost Effectiveness of Asthma CareAmerican Journal of Respiratory and Critical Care Medicine, 1996